TF
CLMT icon

Tompkins Financial’s Calumet Specialty Products CLMT Stock Holding History

Tompkins Financial’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-500
Closed -$14K – 527
2013
Q3 		$14K Hold
500
– – ﹤0.01% 372
2013
Q2 		$18K Buy
+500
New +$18K 0.01% 362

Other funds holding CLMT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tompkins Financial's CLMT Position: Q4 2013 in Review

Tompkins Financial sold out of Calumet Specialty Products (CLMT) in Q4 2013, closing a stake of 500 shares — an estimated $14K sold.

Tompkins Financial first reported a position in CLMT in Q2 2013 and held it in 2 quarters. The position peaked at $18K in Q2 2013. 108 funds tracked by Wall St. Rank hold CLMT as of Q4 2013.

  • Tompkins Financial reported no remaining Calumet Specialty Products position as of Q4 2013 after selling out during the quarter.
  • Tompkins Financial sold 500 Calumet Specialty Products shares in Q4 2013, an estimated $14K.
  • Tompkins Financial first reported a position in Calumet Specialty Products in Q2 2013 and held it in 2 quarters.
  • Tompkins Financial's Calumet Specialty Products position peaked at $18K in Q2 2013.
  • 108 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2013.

Based on Tompkins Financial's 13F filing for Q4 2013, filed 8 Jan 2014.